Cardiology Today's Intervention compiled a list of the top news posted in September. This month, our readers were most interested in transcatheter mitral valve repair for functional mitral regurgitation, long-term oral anticoagulation in patients with atrial fibrillation after stenting, transcatheter aortic valve replacement in patients with low surgical risk and more.
See below for links to the full articles on Healio.com/Intervention.
COAPT: MitraClip reduces hospitalization, mortality in HF, mitral regurgitation
SAN DIEGO — Patients with HF with moderate to severe or severe functional mitral regurgitation who underwent transcatheter mitral valve repair reduced the risk for HF hospitalization and mortality compared with patients treated with medical therapy alone, according to 2-year data from the COAPT trial presented at TCT 2018.
Long-term oral anticoagulation alone not sufficient in AF, CAD after stenting
SAN DIEGO — Noninferiority was not established for oral anticoagulation alone vs. oral anticoagulation with antiplatelet therapy in patients with AF and stable CAD more than 1 year after stenting, according to data from the OAC-ALONE study presented at TCT 2018.
TAVR safe in low-risk patients with severe aortic stenosis
MUNICH — In a prospective trial, no patients with low surgical risk had died or experienced disabling stroke at 30 days after TAVR for symptomatic severe aortic stenosis, Ron Waksman, MD, from MedStar Heart & Vascular Institute at MedStar Washington Hospital Center, said at the European Society of Cardiology Congress.
AI-powered blood test predicts PAD, need for revascularization in patients with diabetes
MUNICH — An artificial intelligence-powered blood test consisting of one clinical variable and six biomarkers predicted with high accuracy the presence of peripheral artery disease and need for revascularization in patients with and without diabetes, researchers reported at the ESC Congress.
MAIN-COMPARE: Outcomes similar in CABG, PCI for left main CAD
SAN DIEGO — Patients with significant left main CAD who underwent PCI had similar rates of death and a composite outcome up to 10 years compared with those who underwent CABG, according to data from the MAIN-COMPARE registry presented at TCT 2018.
FDA approves stent system for acute coronary artery perforations
The FDA announced it has approved a coronary stent system for the treatment of patients with acute coronary artery perforations occurring during PCI.
High triglycerides raise risk for peripheral artery revascularization
MUNICH — Among high-risk patients on statin treatment, those with elevated triglycerides were more likely to undergo peripheral artery revascularization within 5 years, researchers reported at the ESC Congress.
Cardiogenic shock: Current status and future directions
The patient presenting with acute MI and cardiogenic shock has long presented a challenge for physicians. While advances in therapy, including reperfusion and mechanical support, have been associated with improvements in survival, mortality remains high, and there is broad variation in cardiogenic shock outcomes. The complex and urgent nature of shock — coupled with treatment, research and clinical knowledge gaps — creates a need for increased awareness and optimal solutions to care for patients with cardiogenic shock.
IMPERIAL: DES with polymer coating offers superior patency in PAD
SAN DIEGO — Patients with PAD who received a drug-eluting stent with a polymer coating and a lower drug dose density had better patency compared with a DES without a polymer coating and a higher drug dose density, according to 12-month results from the IMPERIAL trial presented at TCT 2018 and published in The Lancet.
Societies set guidelines for acute ischemic stroke interventions
Thirteen neurointerventional societies set guidelines for centers providing acute ischemic stroke interventions, including volume thresholds.